Regulated information

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet".

Mastaplex and Vetoquinol announce distribution agreement

Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest..

Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION

Update July 11, 2023
Vetoquinol published its calendar of financial communication for 2023.

Growth driven by innovation

Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy.

3rd generation appointed chairman of the board of directors of VETOQUINOL SA

At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023.

Universal registration document 2022

Universal Registration Document including the Annual Financial Report

Essential products

Essential products for the most common needs